TherapeuticsMD Initiates Phase I Study of Estradiol VagiCap™ for VVA TherapeuticsMD, Inc. announced today that it has initiated a Phase I study of its TX- 12-004-HR estradiol VagiCap™ for vulvar and vaginal atrophy . Already
Aug. 12, 2013 - Business Wire via Yahoo! Finance